🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementThrew up at work today - do I tell my boss why? — anyone have experience?

Threw up at work today - do I tell my boss why? — anyone have experience?

patPC_UT Wed, Sep 10, 2025 at 12:53 PM 20 replies 1,280 viewsPage 1 of 4
This thread is more than 9 months old. Information may be outdated. Consider searching for more recent discussions.
patPC_UT
Member
212
890
Nov 2024
Park City, UT
Sep 10, 2025 at 12:53 PM#1

This gets cited here weekly, usually second-hand, so it is worth setting out what it does and does not establish.

Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts. Receptor-level tachyphylaxis to the delayed-emptying effect develops over weeks while the central appetite effect persists, so the same dose is materially more comfortable at week six than at week two. A slower ladder therefore reaches the same dose with less cumulative nausea, not the same nausea spread thinner.

Where I think it is weakest: the comparator does most of the work in how this gets reported, and it is not the comparator most people think they are citing.

The question I want answered is whether holding at a lower dose for longer actually reduces total side-effect burden or just spreads it out. Practical detail welcome, however dull — the duller the better.

Note on sourcing:
Figures above are from the primary publication rather than the press summary. If a number here disagrees with one you have, post yours and we will work out which of us is reading a secondary source.
10 5sarah_nash92, FitDadDave, RunnerRach and 7 others
Reply Quote Save Share Report
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Sep 10, 2025 at 1:26 PM#2
patPC_UT said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

That is correct as far as it goes, and here is where it stops going. The line between titrate-through and stop is not severity, it is trajectory and what else is present. Nausea that peaks and improves within a week is the expected pattern. Nausea that is escalating, or that comes with severe upper-abdominal pain radiating to the back, or that prevents fluids for more than a day, is a different conversation and belongs with a clinician the same day.

Last edited: Sep 10, 2025 at 3:26 PM
9 4KristenIndy, MarkLI_maint, Dr.PeteFamMed and 6 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Sep 10, 2025 at 1:59 PM#3
patPC_UT said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

I dislike how confidently this board tells people to push through. Incidence figures around 20 to 25% at the higher doses are class-typical, but the trials also had a discontinuation column, and "manageable with protocols" is not the same as manageable for everyone.

8 3PharmHunterJen, TomTeleRx, DoseLogDan and 5 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Sep 10, 2025 at 2:32 PM#4

Short answer first, then the reasoning. The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the fat fraction of meals in the two days after dosing, and do not lie down straight after eating. Most of what people call unmanageable nausea is a meal-size and meal-composition problem interacting with a stomach that is emptying slowly.

Happy to go further on any of that.

7 2ricardo_MIA, BrianDallas92, labquiet_amy and 4 others
Reply Quote Save Share Report
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Sep 10, 2025 at 5:35 PM#5
VendorMark said:
The line between titrate-through and stop is not severity, it is trajectory and what else is present.

Mine went the same way, slower.

6 1Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 3 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register